Understanding how certain cancer mutations evade the immune system
Deciphering the Immune Evasion Mechanisms in Mutant IDH1 Cancer
This study is looking at how changes in a specific gene can lead to a type of liver cancer by affecting the immune system, and it's using a special mouse model to find ways to boost the body's ability to fight this cancer, which could help improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10984626 on NIH RePORTER |
What this research studies
This research investigates how mutations in the IDH1 gene contribute to the development of intrahepatic cholangiocarcinoma (ICC) by producing a substance that disrupts normal immune responses. Using a specially designed mouse model that mimics human cancer, the study aims to uncover the mechanisms by which these mutations create an environment that suppresses the body's immune system, particularly affecting T cells that fight tumors. The goal is to identify ways to enhance anti-tumor immunity and improve treatment outcomes for patients with this type of cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with intrahepatic cholangiocarcinoma who have mutations in the IDH1 gene.
Not a fit: Patients with other types of cancer or those without IDH1 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance the immune response against bile duct cancer, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in targeting immune evasion mechanisms in cancer, suggesting that this approach could yield significant advancements.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Wu, Meng-Ju — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Wu, Meng-Ju
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.